{"name":"T3D Therapeutics, Inc.","slug":"t3d-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"T3D Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for the treatment of Alzheimer's disease and other neurodegenerative disorders. The company's lead candidate, T3D-959, is currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxPWklsUzM1MWV5UG9OVUZ2MDVxU0dFZXNicklodnpHb1g5UkNrT3BneEVkai14VkdVajl5MEtkUTFlWG9EWG9JYVR5Y2dDYzdSSW9IeEVDdmd6U2tVcGF3UndTcDIyYjdrV1dOdUVfWFhlM3psYU5VQXFwb29sczN2WktwRUhGWFVsakFTVG1hbElBejlYR0VIRThKX3E4aTFhd3JYZS1zMnRUcnAxYXZ1blpfNmhsd1RtTlpLNEpsWUNhQWZEWk1MWWx3blN5dU5PZlJERjFxZ001QWNLeEFKcWV4Nks4ZDdickZpMEU1VS1peDhYaGc0?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"Alzheimer’s Disease Clinical Trial Pipeline Shows Potential with Active Contributions from 200+ Key Companies | DelveInsight - Barchart.com","headline":"Alzheimer’s Disease Clinical Trial Pipeline Shows Potential with Active Contributions from 200+ Key Companies | DelveIns","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQbW5Qb05iTnRLLTg0aEc3SjZjd3l1aE1va3NJRVBaRzVELWZYeFRZT2pzSzBEME1kX1pWSGxXR1ljUEdnb2hhMkItamhnYVktU0pNZjNEZjVqUXA3QkNyeF8tbWExMmNlTV9McDcwZE9xMGx3c3FpaWNyVnRNNFMyV29ZYlplVjVxd3EwTDdQTGZvQ3hJc0hvWUh0N291UkFZbk84bG10WlNqMm8?oc=5","date":"2026-01-07","type":"trial","source":"Science | AAAS","summary":"Alzheimer’s drug developers accuse clinical trial sites of faking data - Science | AAAS","headline":"Alzheimer’s drug developers accuse clinical trial sites of faking data - Science | AAAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNRzdOSk9QYjdPQlBFbFItbmpMU09FcktoeGlvdW5oay1taG1PNnhpRnpwamxlRV9hU0NsRXEtR1dNZ05mY0VTRHUwR0U3cVc5RGZUQ2VPNmlNN2JzaUVWMVNjeU51Y2htTE9KaHJrSUdmM19acjZvcE5pTXVDazRNRHhOWW03SHYyZTMtMW5jSlVYa3drVUhWMnZteGRWWVRYYUFIeTN4NXczYWV4TkIyTGpWN3V6NGFhdkp1c3p4YTZGZjJCOEV6eUc3OU16UTJtaHRzOWd6VzZBSmE4bExfSmd0R3g0QWlZTFRrS3kzN1Z3aGwtbi1xT0dKWUNGNXdKTE80?oc=5","date":"2025-09-05","type":"pipeline","source":"PR Newswire UK","summary":"GLP-1 Agonists Market to Show Impressive Growth at a CAGR of 10.8% During the Forecast Period (2025-2034) | DelveInsight - PR Newswire UK","headline":"GLP-1 Agonists Market to Show Impressive Growth at a CAGR of 10.8% During the Forecast Period (2025-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxQQzZONnNQY1N0YlhhTjlPVmNOS044ZzJZaDJhNXU1elZkTzh4ZXpKS09aN1hyOUxvei16Y2ZyTWNhTFRkQ0ZzVDBRTVhXSnNVcFllOXA5czhXdE0xZ0lYckYzRDZJczBod2JVM3FwRXlhREVseXN1d2NCOTZ0UmlCVGJCYjByV3RPLVBvdzVxU3p5WlZqVHIwODhTaHZuU1kwOENBX0NVbExvNWI3WF9WTGdBMlluQ21rdXRLZ2FWYTZrQU1TdExPRUh6a09TaUEyeDNIenRpOG41d2lUODBjdGNFMWpEN2JYWkh3NkZMT3M?oc=5","date":"2025-08-07","type":"pipeline","source":"The AI Journal","summary":"Progressive Supranuclear Palsy Market on Upward Trajectory During the Forecast Period (2025-2034) with Emerging Immunotherapies | DelveInsight - The AI Journal","headline":"Progressive Supranuclear Palsy Market on Upward Trajectory During the Forecast Period (2025-2034) with Emerging Immunoth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNM2JFeWIwMTFCUi1wZGQ3T2dNTllzVVhXcERhQVpqQXd4c3NxdEwwck1VX0JkWDhvai1zOUZ0MGhjc2RzM3MzNEZyVEkyVUN6UGZBZTAtVkJNdU5JOUZwZnUwdkctNFl0WHpqbVlCQi1VblE4T3hVLUtlUF84MFRzaFlzZE15VkVuQVRMZGRmVEY5cFRyMnlj0gFWQVVfeXFMT3gyVnVuMW1qb0E4MHZqQ2EwSnNsY2pER2JvRGRGSkNoaUI0dHY3cGRLcG9ubUlKOGdSMHpKcV9GZXVJbXhkRTBzckJKMzhEODBLdEw1Snc?oc=5","date":"2025-07-28","type":"trial","source":"Law360","summary":"Pharma Co. Alleges Clinical Trial Data Was Fabricated - Law360","headline":"Pharma Co. Alleges Clinical Trial Data Was Fabricated - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAJBVV95cUxPd3QyQ0JRbGF1TWJBNGZBTXJRWnV1a1hHVGgwcG5DUUFfMmZGYmlYQnpab3ZBVDhkQlU4cVpOdzZpcHd6NWFPbHhJMkkwcGtDbmQ3c0xUSk1kX055NXN1QzNvbzI3Um1BQ3U2WVlWWWtWUzRZWlBob09CdENuZm4zcGRQdThqbFRZNFNBeXBldVpNZTdWMl9tMmRiMHpHMFA4NnZWblRQTVJVMXhScjRjUXVuUmdBYjFBcDA3djNOaXJ5emNId29xN21VRE16SVk0RDhWcFNfR2NQV3pDUy1fLXBWLWZMRFYyOHYxYzJpa1VEWUtlRVpPNUdSRUxraUZESzhPWEZPdHVCNFRLVTdSbG9icUJaQWhyS050WjNzckRFaWpIYWF3cjVUWjQ4dkZUYTlCRlBadjNadHl4OXJtLXQ5dDJnVmc2?oc=5","date":"2025-07-08","type":"pipeline","source":"GlobeNewswire","summary":"Alzheimer’s Therapeutics Market on Upward Trajectory Across - GlobeNewswire","headline":"Alzheimer’s Therapeutics Market on Upward Trajectory Across","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPZFUxUExHTmV3MGtXaXhGUWZiV0NnRmlDNWkzQVdYZzFVMDVuQlNjRkNTTURuOVdCNVZlUGdocFpEVE01N0ZyNHAxaVI5WkViQ2NOV3FsdFlUdWtPM1ZEaDdseDFFQ1RZN2I5MnpPMXkwei15S01Cel9hVmxuUG15dWtBN3AyTUk?oc=5","date":"2025-02-11","type":"pipeline","source":"Charlotte Observer","summary":"Everything you need to know about NIH cuts (+ how they could cause ‘massive layoffs’ in NC) - Charlotte Observer","headline":"Everything you need to know about NIH cuts (+ how they could cause ‘massive layoffs’ in NC)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPdnVMTGt6WHhydGNISkIwSDVZekdtOVNwYU41RHMyQ1VZN0QxUDJRd1BzSnpiR1BXdGFWLWV4SjBzUjk0UVFLTUlObHY4d3BYcUhYb3VsTGhySFFoYU9UU0NhNTk4WUI0V21kZS0wdHJUMUVWcnpaeXJ2XzMtMHRsTW16dzRXYmswaER2Rk12a0pqZTlNc0V6SGJjSQ?oc=5","date":"2024-10-01","type":"pipeline","source":"Life Science Leader","summary":"Annovis Bio: Against The Grain In Alzheimer's Disease - Life Science Leader","headline":"Annovis Bio: Against The Grain In Alzheimer's Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxQanhrZ3JEUEcxR180ZFozLWtMcVgyaFZpdVBBZHl2aUJ4alNTQjA3bGNXaUwzei1mM2dLSUYxOUNGbFVsbDluRFlGMUFIa0ZDWXF5MnZ3RG9YeUh3TjJycHJjR1JFd05hVmxzYXZROW15UWpkOUZ5MVZxaDU5OW1NRUkxdGc0MVJHdkYydThXWDdUM2YxS3pDRmtwenludTBXRUJ5MVlXX2tXTjlCd1Noa2ZsZmFZd2cxQTZKMnFDOFNZd0dxa3BLbWE1M1c3WE5ORmlKeGN2YnJXNThYYWRRSmRYZDhNVUw4RElpdG12c3BMWDlFOWx3QWxLUWQ2WVFub1FtN19zVVFacFJZc29ycF9RWjNDeGVfYkE?oc=5","date":"2022-04-26","type":"pipeline","source":"PR Newswire","summary":"Alzheimer's Disease Therapeutics Market 2022-2026 | Availability, Research, and Development of Novel Biomarkers to Boost Growth | Technavio - PR Newswire","headline":"Alzheimer's Disease Therapeutics Market 2022-2026 | Availability, Research, and Development of Novel Biomarkers to Boost","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}